Literature DB >> 12482039

Psychiatric morbidity in vitiligo: prevalence and correlates in India.

S K Mattoo1, S Handa, I Kaur, N Gupta, R Malhotra.   

Abstract

BACKGROUND: Vitiligo, a common pigmentary disorder, is recognized to be associated with a high psychiatric morbidity, yet compared to other dermatological disorders like leprosy, psoriasis, etc., it has not been subjected to detailed evaluation of its psychological consequences. The data from the developing countries on this aspect in particular is meager.
METHODS: One hundred and thirteen cases with vitiligo were evaluated along with 55 healthy controls comparable for sociodemographic profile and matched on attitude to appearance scale. Clinical details, impact of illness, associated dysfunction and psychological morbidity were additionally assessed.
RESULTS: Twenty-eight patients with vitiligo were found to have psychiatric morbidity, a clinic prevalence rate of 25% (95% confidence interval 20.3-29.3%). The majority of the cases had a diagnosis of adjustment disorder. Psychiatric morbidity was significantly correlated with dysfunction arising out of illness.
CONCLUSIONS: Vitiligo is associated with high psychiatric morbidity. There is a need to develop cross-cultural database on psychosocial aspects and psychiatric morbidity associated with vitiligo.

Entities:  

Mesh:

Year:  2002        PMID: 12482039     DOI: 10.1046/j.1468-3083.2002.00590.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  30 in total

1.  Dermatology Specific Quality of Life in Vitiligo Patients and Its Relation with Various Variables: A Hospital Based Cross-sectional Study.

Authors:  Nitin Mishra; Madhur K Rastogi; Pratik Gahalaut; Shikha Agrawal
Journal:  J Clin Diagn Res       Date:  2014-06-20

2.  Psychosocial morbidity in acromegaly: a study from India.

Authors:  Surendra Kumar Mattoo; Anil Kumar Bhansali; Nitin Gupta; Sandeep Grover; Ramma Malhotra
Journal:  Endocrine       Date:  2008-10-25       Impact factor: 3.633

3.  Psychosocial morbidity in Cushing disease: a study from India.

Authors:  Surendra Kumar Mattoo; Anil Kumar Bhansali; Nitin Gupta; Sandeep Grover; Rama Malhotra
Journal:  Endocrine       Date:  2009-04-09       Impact factor: 3.633

4.  State of Consultation-Liaison Psychiatry in India: Current status and vision for future.

Authors:  Sandeep Grover
Journal:  Indian J Psychiatry       Date:  2011-07       Impact factor: 1.759

5.  Understanding mechanisms of vitiligo development in Smyth line of chickens by transcriptomic microarray analysis of evolving autoimmune lesions.

Authors:  Fengying Shi; Byung-Whi Kong; Joon Jin Song; Jeong Yoon Lee; Robert L Dienglewicz; Gisela F Erf
Journal:  BMC Immunol       Date:  2012-04-13       Impact factor: 3.615

6.  Dermatology life quality index scores in vitiligo: reliability and validity of the Tunisian version.

Authors:  Akrem Jalel; Gaigi Siala Soumaya; Mohamed Hédi Hamdaoui
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

7.  Meta-Analytic Review of High Anxiety Comorbidity among Patients with Vitiligo.

Authors:  Jiani Liu; Rui Tang; Yangfan Xiao; Mei Luo; Yaqian Shi; Qiancheng Deng; Huiming Zhang; Zhoutong Zeng; Zixin Pi; Rong Xiao
Journal:  Biomed Res Int       Date:  2021-05-17       Impact factor: 3.411

8.  Relapse after methylprednisolone oral minipulse therapy in childhood vitiligo: a 12-month follow-up study.

Authors:  Imran Majid; Saher Imran
Journal:  Indian J Dermatol       Date:  2013-03       Impact factor: 1.494

Review 9.  Quality of life in patients with vitiligo.

Authors:  Davinder Parsad; Sunil Dogra; Amrinder Jit Kanwar
Journal:  Health Qual Life Outcomes       Date:  2003-10-23       Impact factor: 3.186

10.  DLQI scores in vitiligo: reliability and validity of the Persian version.

Authors:  Shahin Aghaei; Manouchehr Sodaifi; Peyman Jafari; Nazila Mazharinia; Andrew Y Finlay
Journal:  BMC Dermatol       Date:  2004-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.